120 related articles for article (PubMed ID: 9568608)
1. Irinotecan hydrochloride: drug profile and nursing implications of a topoisomerase I inhibitor in patients with advanced colorectal cancer.
Berg D
Oncol Nurs Forum; 1998 Apr; 25(3):535-43. PubMed ID: 9568608
[TBL] [Abstract][Full Text] [Related]
2. Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group.
Van Cutsem E; Blijham GH
Semin Oncol; 1999 Feb; 26(1 Suppl 5):13-20. PubMed ID: 10213010
[TBL] [Abstract][Full Text] [Related]
3. New agents in gastrointestinal malignancies: Part 1: Irinotecan in clinical practice.
Stucky-Marshall L
Cancer Nurs; 1999 Jun; 22(3):212-9. PubMed ID: 10376382
[TBL] [Abstract][Full Text] [Related]
4. [Irinotecan: various administration schedules, study of drug combinations, phase I experience].
Boige V; Raymond E; Armand JP
Bull Cancer; 1998 Dec; Spec No():26-32. PubMed ID: 9932081
[TBL] [Abstract][Full Text] [Related]
5. Irinotecan hydrochloride.
Wilkinson K
Clin J Oncol Nurs; 2001; 5(4):179-80, 184. PubMed ID: 12690622
[No Abstract] [Full Text] [Related]
6. A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma.
Rothenberg ML; Cox JV; DeVore RF; Hainsworth JD; Pazdur R; Rivkin SE; Macdonald JS; Geyer CE; Sandbach J; Wolf DL; Mohrland JS; Elfring GL; Miller LL; Von Hoff DD
Cancer; 1999 Feb; 85(4):786-95. PubMed ID: 10091755
[TBL] [Abstract][Full Text] [Related]
7. CPT-11 in the treatment of colorectal cancer: clinical efficacy and safety profile.
Rougier P; Bugat R
Semin Oncol; 1996 Feb; 23(1 Suppl 3):34-41. PubMed ID: 8633252
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and toxicity of irinotecan in patients with colorectal cancer.
Rothenberg ML
Semin Oncol; 1998 Oct; 25(5 Suppl 11):39-46. PubMed ID: 9786315
[TBL] [Abstract][Full Text] [Related]
9. [Taxotere (docetaxel) and CPT 11 (irinotecan): phase I trials].
Couteau C; Yakendji K; Terret C; Goncalves E; Armand JP
Bull Cancer; 1996 Jan; 83(1):3-10. PubMed ID: 8672854
[TBL] [Abstract][Full Text] [Related]
10. US pivotal studies of irinotecan in colorectal carcinoma.
Pitot HC
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):48-53. PubMed ID: 9726091
[TBL] [Abstract][Full Text] [Related]
11. Setting a new standard--irinotecan (Campto) in the second-line therapy of colorectal cancer: final results of two phase III studies and implications for clinical practice.
Cunningham D
Semin Oncol; 1999 Feb; 26(1 Suppl 5):1-5. PubMed ID: 10213008
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
13. Irinotecan. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.
Wiseman LR; Markham A
Drugs; 1996 Oct; 52(4):606-23. PubMed ID: 8891470
[TBL] [Abstract][Full Text] [Related]
14. Irinotecan: a new antineoplastic agent for the management of colorectal cancer.
Cersosimo RJ
Ann Pharmacother; 1998 Dec; 32(12):1324-33. PubMed ID: 9876815
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase I inhibitors in the treatment of colorectal cancer.
Rothenberg ML; Blanke CD
Semin Oncol; 1999 Dec; 26(6):632-9. PubMed ID: 10606256
[TBL] [Abstract][Full Text] [Related]
16. Irinotecan in epithelial ovarian cancer.
Gershenson DM
Oncology (Williston Park); 2002 May; 16(5 Suppl 5):29-31. PubMed ID: 12109803
[TBL] [Abstract][Full Text] [Related]
17. A phase III study of irinotecan (CPT-11) versus best supportive care in patients with metastatic colorectal cancer who have failed 5-fluorouracil therapy. V301 Study Group.
Cunningham D; Glimelius B
Semin Oncol; 1999 Feb; 26(1 Suppl 5):6-12. PubMed ID: 10213009
[TBL] [Abstract][Full Text] [Related]
18. UFT plus calcium folinate/irinotecan in colorectal cancer.
Twelves C
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):51-4. PubMed ID: 10442362
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan plus 5-FU and leucovorin in advanced colorectal cancer: North American trials.
Goldberg RM; Erlichman C
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):59-63. PubMed ID: 9726093
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials with the topoisomerase I inhibitors.
Burris HA; Rothenberg ML; Kuhn JG; Von Hoff DD
Semin Oncol; 1992 Dec; 19(6):663-9. PubMed ID: 1334279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
